JB/CALL/ROCHE GS/275/0.02/20.09.24 Stock

Warrant

ROTVJB

CH1242800295

Market Closed - Bid/Ask 11:20:00 2024-05-22 am EDT After market 11:15:00 am
0.028 CHF -12.50% Intraday chart for JB/CALL/ROCHE GS/275/0.02/20.09.24 0.023 -17.86%
3 months-30.00%
6 months-65.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-22 0.028 -12.50%
24-05-17 0.032 +6.67%
24-05-16 0.03 +76.47%

Delayed Quote Swiss Exchange

Last update May 22, 2024 at 11:20 am EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Bank Julius Bär
ROTVJB
ISINCH1242800295
Date issued 2023-03-03
Strike 275 CHF
Maturity 2024-09-20 (119 Days)
Parity 50 : 1
Emission price 0.41 CHF
Emission volume N/A
Settlement les deux
Currency CHF

Technical Indicators

Highest since issue 0.68 CHF
Lowest since issue 0.014 CHF
Delta0.09x
Omega 18.42
Premium19.75x
Gearing200.52x
Moneyness 0.8385
Difference Strike 44.6 CHF
Difference Strike %+16.22%
Spread 0.01 CHF
Spread %35.71%
Theoretical value 0.0230
Implied Volatility 21.53 %
Total Loss Probability 92.70 %
Intrinsic value 0.000000
Present value 0.0230
Break even 276.15 CHF
Theta-0x
Vega0x
Rho0x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
232.1 CHF
Average target price
279.8 CHF
Spread / Average Target
+20.57%
Consensus
  1. Stock Market
  2. Warrants
  3. ROTVJB Warrant